| | 134523-00-5 Basic information More.. |
| Product Name: | Atorvastatin | | Synonyms: | Atorvastatin&Ats-5Ats-8Ats-9M4L1;Atrovastitne;(bR,dR)-2-(p-Fluorophenyl)-β,δ-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid;1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (βR,δR)-;1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, [R-(R*,R*)]-;Cardyl;[R-(R^<*>^，R^<*>^)]-2-(4-Fluorophenyl)- β，δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylarnino)carbonyl]-1H．Pyrrole-1- heptanoic acid;(3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-enanthic acid | | CAS: | 134523-00-5 | | MF: | C33H35FN2O5 | | MW: | 558.65 | | EINECS: | 806-698-0 | | Mol File: | 134523-00-5.mol |  |
Use
Atorvastatin, [R-(R*,R*)]-2-(4-fluorophenyl)-b,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-lH-pyrrole-1-heptanoic acid(Lipitor), also possesses the heptanoic acid side chain,which is critical for inhibition of HMG-CoA reductase.Although the side chain is less lipophilic than the lactoneform, the high amount of lipophilic substitution causes this agent to have a slightly higher level of CNS penetration thanpravastatin, resulting in a slight increase in CNS side effects.Even so, its CNS profile is much lower than that of lovastatin.Atorvastatin is marketed as a combination therapywith amlodipine under the trade name Norvasc for managementof high cholesterol and high blood pressure.
- Atorvastatin
-
- 2026-05-29
- CAS:134523-00-5
- Min. Order: 1KG
- Purity: 99%, USP
- Supply Ability: 5,000KG
- Atorvastatin
-
- $484.00
- 2026-05-15
- CAS:134523-00-5
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 100KG
- Atorvastatin
-
- 2026-05-08
- CAS:134523-00-5
- Purity: 99.69%
- Supply Ability: 10g
|
|
134523-00-5
Recommend Suppliers |
|